Beacon Equity Research: 3 Cheap Healthcare Stocks in the News
DepoMed Inc. (NASDAQ: DEPO), a specialty pharmaceutical company engaged in the development and commercialization of differentiated products, earlier this week announced that its GRALISE™ tablets are now available as a once-daily treatment for postherpetic neuralgia. Jim Schoeneck, president and CEO of DepoMed, said earlier this week that the launch of GRALISE is a major milestone for the company. He added that the company also received positive reactions from insurers and expects to have broad managed care coverage. Synergetics Inc. (NASDAQ: SURG), a medical device company, on Tuesday released its fourth-quarter financial results. The company reported fourth-quarter net income of $2…